UP-2.187: Long Follow-Up Study of Original Orthotopic Ileal Neobladder Reconstruction in 61 Patients with Bladder Cancer

Urology ◽  
2009 ◽  
Vol 74 (4) ◽  
pp. S290-S291
Author(s):  
J. Zheng ◽  
H. Zhang ◽  
Y. Chao ◽  
Y. Xu ◽  
B. Peng ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Ileal Neobladder ◽  
Follow Up Study ◽  
Orthotopic Ileal Neobladder

A Combined Technique for Radical Cystoprostatectomy and Orthotopic Ileal Neobladder

2003 ◽  
Vol 70 (1-4) ◽  
pp. 22-28
Author(s):  
A. Simonato ◽  
A. Lissiani ◽  
A. Gregori ◽  
A. Bozzola ◽  
S. Galli ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Oncological Outcome ◽  
Anatomical Landmarks ◽  
Ileal Neobladder ◽  
Radical Cystoprostatectomy ◽  
Estimated Blood Loss ◽  
The Mean ◽  
Combined Technique ◽  
Orthotopic Ileal Neobladder

After anatomical and surgical studies on cadavers we developed a combined technique for radical cystoprostatectomy with orthotopic ileal neobladder labelled M.I. La. N. (Minimally Invasive Laparoscopic Neobladder). The aim of this technique is to combine the advantages of open and laparoscopic surgery. Between June 2001 and July 2002, 6 men aged 65 to 72 underwent combined radical cystoprostatectomy with orthotopic ileal neobladder for organ-confined bladder cancer. The M.I. La.N. consists of 3 steps: 1) laparoscopic radical cystoprostatectomy and bilateral pelvic lymph node dissection; 2) external partial fashioning of the neobladder and side-to-side bowel anastomosis; 3) laparoscopic lower urinary tract reconstruction. The mean time of the overall procedure was 425 minutes (range 360 to 510). Mean estimated blood loss was 312 mL (range 220 to 440). Mean hospital stay was 8.1 days (range 7 to 9). Histopathology revealed 1 pT1N0 G3 plus carcinoma in situ (Cis), 1 pT2aN0 G3 plus Cis, 4 pT2bN0 G2-3. The surgical margins were tumor free. At the time of analysis (October 2003) the mean follow-up is 18.1 months (range 15 to 21). Two patients respectively stage pT1N0 + Cis and pT2bN0 G2-3 died for metastatic disease at 20 and 18 months after the operation. One patient stage pT2aN0 plus Cis died for unrelated causes free from disease after 16 months from the procedure. The remaining 3 patients are alive and free from disease. The combined technique for radical cystoprostatectomy with orthotopic ileal neobladder (“M.I. La. N.”) can reproduce open surgery. Moreover, it provides an anatomic approach, familiar to most urologist and anatomical landmarks are easy to follow. In our opinion, the combined approach does not reduce the advantages of laparoscopy. We know that this technique may require a long learning curve and it is still a pioneristic procedure. A strict follow up is necessary to evaluate the oncological outcome that is still unpredictable for the low number of treated patients and for biology of bladder cancer.

733: The Prognostic Value of E-Cadherin, Alpha-, and Beta-Catenin in Invasive Bladder Cancer Patients: Long Term Follow-Up Study

2004 ◽  
Vol 171 (4S) ◽  
pp. 194-195
Author(s):  
Kyoichi Tomita ◽  
Haruki Kume ◽  
Keishi Kashibuchi ◽  
Satoru Muto ◽  
Shigeo Horie ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Patients ◽  
Prognostic Value ◽  
Invasive Bladder Cancer ◽  
Beta Catenin ◽  
Follow Up Study ◽  
Long Term Follow Up ◽  
E Cadherin

Serum Paraoxonase-1 Concentration as a Potential Predictor of Urinary Bladder Cancer Recurrence. A Five Year Follow-Up Study

2018 ◽  
Vol 49 (2) ◽  
pp. 119-122 ◽  
Author(s):  
Simona Iftimie ◽  
Anabel García-Heredia ◽  
Francesc Pujol-Bosch ◽  
Antoni Pont-Salvadó ◽  
Ana Felisa López-Azcona ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Urinary Bladder ◽  
Cancer Recurrence ◽  
Urinary Bladder Cancer ◽  
Paraoxonase 1 ◽  
Potential Predictor ◽  
Follow Up Study ◽  
Serum Paraoxonase ◽  
Bladder Cancer Recurrence

scholarly journals Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan

2020 ◽  
Vol 25 (6) ◽  
pp. 1163-1169
Author(s):  
Atsushi Ikeda ◽  
Takahiro Kojima ◽  
Koji Kawai ◽  
Shiro Hinotsu ◽  
Naoto Keino ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Positive Result ◽  
Recurrence Rates ◽  
Follow Up Study ◽  
Negative Results ◽  
Negative Findings ◽  
History Of ◽  
Muscle Invasive ◽  
Positive Results

Abstract Background A previous comparative study in Japan has demonstrated that the two consecutive UroVysion tests are useful tools to detect the presence of bladder cancer during follow-up after transurethral resection, but they also presented their high rates of false-positive results. Here, we aimed to evaluate the relationship between the UroVysion tests and subsequent intravesical recurrence. Methods In the previous study, patients without bladder cancer during the first analysis showed the same examination set repeated 3 months later as the second analysis. In this follow-up study, 326 patients showed negative findings confirmed on cystoscopy during the second UroVysion test. Recurrence-free survival was assessed using a median follow-up of 27 months. Results In the two consecutive UroVysion tests, 214 patients (65.6%) showed negative UroVysion results in both tests, whereas 91 presented a positive result on either tests and 21 patients presented positive results in both tests. During the follow-up, 40 patients (12.3%) had an intravesical recurrence with non-muscle-invasive bladder cancer. The recurrence rates in patients with negative results in both tests, those with one positive result in either tests, and those with positive results in both tests were 8.4%, 16.5%, and 33.3%, respectively. The multivariate analysis indicated that the history of bladder cancer and the consecutive UroVysion test pattern were independent risk factors for recurrence. Conclusions Our data confirmed the effectiveness of two consecutive UroVysion tests in predicting intravesical recurrence after TURBT. Further prospective studies would help determine an appropriate interval for cystoscopy follow-up.

Sign in / Sign up

Export Citation Format

Share Document